- £116.79m
- £85.51m
- £62.73m
- 72
- 44
- 12
- 34
Annual income statement for hVIVO, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 20.6 | 36.9 | 48.5 | 56 | 62.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 31 | 36.3 | 49.4 | 45.9 | 49.9 |
| Operating Profit | -10.4 | 0.59 | -0.934 | 10.1 | 12.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -11.2 | 0.277 | -0.365 | 11.1 | 13.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -10.8 | -0.074 | -0.776 | 16.1 | 10.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -10.8 | -0.074 | -0.776 | 16.1 | 10.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10.8 | -0.074 | -0.776 | 16.1 | 10.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.016 | -0.001 | 0.006 | 0.024 | 0.015 |
| Dividends per Share | |||||
| Special Dividends per Share |